ResourceLife Sciences
Introducing Onco-Hu mouse models
6 Feb 2024In this application note, The Jackson Laboratory presents its research on humanized mice, specifically the comparison between NSG and NSG-SGM3 mice engrafted with CD34+ human hematopoietic progenitor cells (HPCs) from the same donor. The study evaluates the humanization levels in these mice and their efficacy in cancer models, particularly their response to anti-PD-1 therapy with pembrolizumab. The results suggest that PDX-bearing NSG-SGM3 mice could serve as an improved platform for preclinical immuno-oncology efficacy studies.
Related Products
Request Quote for All Products
JAX® Mice and Services
The Jackson LaboratoryTake advantage of our large inventories of common inbred strains and the convenience of having your breeding and drug efficacy needs met by the leading experts in mouse modeling.